SCHEMBL6945290

SCHEMBL6945290

c1ccc(CC2CC3CCC(C2)N3Cc2nc3cncnc3[nH]2)cc1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 4/20 0.43
GRIN2B Q13224 4/20 0.43
KCNH2 Q12809 2/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ROCK2 O75116 2/20 0.37
ARHGDIA P52565 2/20 0.37
ROCK1 Q13464 2/20 0.37
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6943216 0.85 GRIN2B (0.47) GRIN1GRIN2BKCNH2OPRM1OPRD1
SCHEMBL7241045 0.83 GRIN1 (0.65) GRIN1GRIN2BALDH1A1THRB
SCHEMBL7073777 0.82 GRIN2B (0.52) GRIN1GRIN2BKCNH2OPRM1OPRD1
SCHEMBL7072578 0.80 GRIN2B (0.67) GRIN1GRIN2BCYP2D6
SCHEMBL6943866 0.76 DRD4 (0.39) GRIN1GRIN2BKCNH2OPRM1OPRD1
SCHEMBL6944380 0.73 HTR1A (0.40) GRIN1GRIN2BOPRM1OPRD1
SCHEMBL5133609 0.72 GAA (0.53) GRIN1GRIN2BCYP1A2CYP2C9CYP2C19
SCHEMBL7074921 0.72 GRIN2B (0.56) GRIN1GRIN2BALDH1A1CYP3A4CYP2D6
SCHEMBL7075826 0.72 GRIN1 (0.56) GRIN1GRIN2BALDH1A1
SCHEMBL7074975 0.72 GRIN1 (0.56) GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP claimed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP claimed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO claimed
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP disclosed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP disclosed
US-6432976-B1 ANALGESICS; SIDE EFFECT REDUCTION MERCK & CO., INC. 2002-08-13 US disclosed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed